Relationship Between Paraoxonase-1 Genotype and Activity, and Major Adverse Cardiovascular Events and Malignancies in Patients With Rheumatoid Arthritis Receiving Tofacitinib.

Charles-Schoeman, Christina; Hyde, Craig; Guan, Shunjie; Parikh, Neil; Wang, Jennifer; Shahbazian, Ani; Stockert, Lori; Andrews, John

Charles-Schoeman, Christina; Hyde, Craig; Guan, Shunjie; Parikh, Neil; Wang, Jennifer; Shahbazian, Ani; Stockert, Lori; Andrews, John.

Afiliação

Charles-Schoeman C; C. Charles-Schoeman, MD, MS, Department of Medicine, Division of Rheumatology, University of California Los Angeles, Los Angeles, California.
Hyde C; C. Hyde, PhD, Pfizer Inc, Groton, Connecticut.
Guan S; S. Guan, PhD, Pfizer Inc, Cambridge, Massachusetts.
Parikh N; N. Parikh, MD, Department of Medicine, Division of Rheumatology, University of California Los Angeles, Los Angeles, California.
Wang J; J. Wang, BS, Department of Medicine, Division of Rheumatology, University of California Los Angeles, Los Angeles, California.
Shahbazian A; A. Shahbazian, BS, Department of Medicine, Division of Rheumatology, University of California Los Angeles, Los Angeles, California.
Stockert L; L. Stockert, RDN, MS, Pfizer Inc, Collegeville, Pennsylvania, USA.
Andrews J; J. Andrews, MD, Pfizer Inc, Collegeville, Pennsylvania, USA.

J Rheumatol ; 2023 Jul 15.

Article em En | MEDLINE | ID: mdl-37453736

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article